Skip to content

Clinical trials

Phase 4 Bipolar Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 4 Country / region: United States Clear all

155 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20016
20026
20039
200410
200519
200613
200718
20088
20096
20109
20117
20123
20131
20144
20155
20163
20175
20182
20193
20202
20212
20233
20252
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed120
Terminated16
Withdrawn6
Recruiting6
Unknown status5
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital20
New York State Psychiatric Institute10
University of Texas Southwestern Medical Center10
Eli Lilly and Company8
Stanford University6
The University of Texas Health Science Center at San Antonio6
Mayo Clinic5
University Hospitals Cleveland Medical Center5
Icahn School of Medicine at Mount Sinai4
Indiana University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder155
Mania22
Psychotic Disorders21
Schizophrenia20
Major Depressive Disorder12
Alcoholism11
Substance-Related Disorders6
Anxiety Disorders5
Depressive Disorder5
Generalized Anxiety Disorder4

Trials

Showing 1 to 25 of 155. Each trial links to its page on Pharma Observatory.

55 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.